Finally, we found that high tumor CCR10 expression is predictive of worse overall survival in myeloma patients and CCR10 expression is increased in relapsed myeloma tumors relative to newly diagnosed, as well as high-risk genotypes (Fig. 2C, D, Supplementary Fig. 3A–G). The gene discussed is CCR10; the disease is plasma cell myeloma.